Thermosensitive nanosystems associated with hyperthermia for cancer treatment
| dc.creator | Isabela Pereira Gomes | |
| dc.creator | Jaqueline Aparecida Duarte | |
| dc.creator | Ana Luiza Chaves Maia | |
| dc.creator | Domenico Rubello | |
| dc.creator | Danyelle M. Townsend | |
| dc.creator | André Luís Branco de Barros | |
| dc.creator | Elaine Amaral Leite | |
| dc.date.accessioned | 2023-07-17T20:27:58Z | |
| dc.date.accessioned | 2025-09-08T23:38:47Z | |
| dc.date.available | 2023-07-17T20:27:58Z | |
| dc.date.issued | 2019 | |
| dc.identifier.doi | https://doi.org/10.3390/ph12040171 | |
| dc.identifier.issn | 1424-8247 | |
| dc.identifier.uri | https://hdl.handle.net/1843/56502 | |
| dc.language | por | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Pharmaceuticals | |
| dc.rights | Acesso Aberto | |
| dc.subject | Cancer - Tratamento | |
| dc.subject.other | Hyperthermia | |
| dc.subject.other | Thermosensitive systems | |
| dc.subject.other | Cancer treatment | |
| dc.title | Thermosensitive nanosystems associated with hyperthermia for cancer treatment | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 22 | |
| local.citation.issue | 4 | |
| local.citation.spage | 1 | |
| local.citation.volume | 12 | |
| local.description.resumo | Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use. | |
| local.identifier.orcid | https://orcid.org/0000-0001-7750-036X | |
| local.identifier.orcid | https://orcid.org/0000-0001-6841-3061 | |
| local.identifier.orcid | https://orcid.org/0000-0003-1592-7936 | |
| local.identifier.orcid | https://orcid.org/0000-0003-3885-9374 | |
| local.identifier.orcid | https://orcid.org/0000-0003-4679-1891 | |
| local.identifier.orcid | https://orcid.org/0000-0002-7641-6585 | |
| local.identifier.orcid | https://orcid.org/0000-0001-8812-3811 | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS | |
| local.publisher.department | FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.mdpi.com/1424-8247/12/4/171 |